T-cell-biased immune responses generated by a mucosally targeted adenovirus-σ1 vaccine

Lehner, 2002, Mucosal immunity and vaccination against HIV, AIDS, 16, S125, 10.1097/00002030-200216004-00017 Simecka, 1998, Mucosal immunity of the gastrointestinal tract and oral tolerance, Adv. Drug Deliv. Rev, 34,, 235, 10.1016/S0169-409X(98)00042-8 Kaneko, 2000, Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein, Virology, 267,, 8, 10.1006/viro.1999.0093 Bergelson, 1997, Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5, Science (New York, NY), 275,, 1320, 10.1126/science.275.5304.1320 Wickham, 1993, Integrins avb3 or avb5 promote adenovirus internalization but not virus attachment, Cell, 73,, 309, 10.1016/0092-8674(93)90231-E Zabner, 1997, Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection, J. Clin. Invest, 100,, 1144, 10.1172/JCI119625 Grubb, 1994, Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans, Nature, 371,, 802, 10.1038/371802a0 Mercier, 2004, A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1, Proc. Natl. Acad. Sci. USA, 101,, 6188, 10.1073/pnas.0400542101 Chappell, 1997, Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1, J. Virol, 71,, 1834, 10.1128/jvi.71.3.1834-1841.1997 Forrest, 2003, Structure-function analysis of reovirus binding to junctional adhesion molecule 1: implications for the mechanism of reovirus attachment, J. Biol. Chem, 278,, 48434, 10.1074/jbc.M305649200 Von Seggern, 2000, Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein–Barr virus-transformed B cells, J. Virol, 74,, 354, 10.1128/JVI.74.1.354-362.2000 Campos, 2004, Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda red recombination, Hum. Gene Ther, 15,, 1125, 10.1089/hum.2004.15.1125 Mok, 2005, Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses, Mol. Ther, 11,, 66, 10.1016/j.ymthe.2004.09.015 Hofherr, 2008, Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression, Mol. Ther, 16,, 1276, 10.1038/mt.2008.86 Mercier, 2007, Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules, Vaccine, 25,, 8687, 10.1016/j.vaccine.2007.10.030 Gottschalk, 2003, Generating CTLs against the subdominant Epstein–Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies, Blood, 101,, 1905, 10.1182/blood-2002-05-1514 Leen, 2004, Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications, Blood, 103,, 1011, 10.1182/blood-2003-07-2449